Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wirrell, E. C.
Right arrow Articles by Dooley, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wirrell, E. C.
Right arrow Articles by Dooley, J. M.
NEUROLOGY 1996;47:912-918
© 1996 American Academy of Neurology

Long-term prognosis of typical childhood absence epilepsy

Remission or progression to juvenile myoclonic epilepsy E. C. Wirrell, MD, FRCP(C), C. S. Camfield, MD, FRCP(C), P. R. Camfield, MD, FRCP(C), K. E. Gordon, MD, MS, FRCP(C) and J. M. Dooley, MD, FRCP(C)

From the IWK Hospital for Children, Halifax, Nova Scotia, Canada.
Dr. Wirrell was supported by fellowships from Epilepsy Canada/Parke Davis and from the IWK Board of Governors.
Received December 22, 1995. Accepted in final form February 15, 1996.
Address correspondence and reprint requests to Dr. C. Camfield, Dept. of Paediatric Neurology, IWK Hospital for Children, 5850 University Ave., Halifax, Nova Scotia, Canada B3J 3G9.

Objective: To determine the proportion and characteristics of children presenting with childhood absence epilepsy (CAE) who were not taking anti-epileptic drugs (AEDs) and were seizure-free over the last year of long-term follow-up. Methods: For case finding, centralized EEG records for the province of Nova Scotia allowed identification of all children with typical CAE diagnosed between 1977 and 1985. Follow-up was done in 1994 to 1995. Results: Of 81 children with CAE, 72 (89%) were contacted for follow-up. Mean age at seizure onset was 5.7 years (range, 1 to 14 years) and at follow-up was 20.4 years (range, 12 to 31 years). Forty-seven (65%) were in remission. Twelve others (17%) were not taking AEDs but continued to have seizures. Thirteen (18%) were taking AEDs; five were seizure-free over the last year (in four of these a trial without AEDs had previously failed). Fifteen percent of the total cohort had progressed to juvenile myoclonic epilepsy (JME). Multiple clinical and EEG factors were examined as predictors of outcome. Factors predicting no remission (p < 0.05) included cognitive difficulties at diagnosis, absence status prior to or during AED treatment, development of generalized tonic clonic or myoclonic seizures after onset of AEDs, abnormal background on initial EEG, and family history of generalized seizures in first-degree relatives. Conclusions: Only 65% of children presenting with CAE had remission of their epilepsy. Forty-four percent of those without remission had developed JME. At the time of diagnosis, remission is difficult to predict accurately in most patients. However, development of generalized tonic-clonic seizures or myoclonic seizures during AED treatment is ominous, predicting both lack of remission of CAE and progression to JME.

NEUROLOGY 1996;47: 912-918




This article has been cited by other articles:


Home page
NeurologyHome page
C. S. Camfield and P. R. Camfield
Juvenile myoclonic epilepsy 25 years after seizure onset: A population-based study
Neurology, September 29, 2009; 73(13): 1041 - 1045.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
E. Tovia, H. Goldberg-Stern, E. Shahar, and U. Kramer
Outcome of Children With Juvenile Absence Epilepsy
J Child Neurol, September 1, 2006; 21(9): 766 - 768.
[Abstract] [PDF]


Home page
BrainHome page
I. E. Martinez-Juarez, M. E. Alonso, M. T. Medina, R. M. Duron, J. N. Bailey, M. Lopez-Ruiz, R. Ramos-Ramirez, L. Leon, G. Pineda, I. P. Castroviejo, et al.
Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up
Brain, May 1, 2006; 129(5): 1269 - 1280.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Sankar
Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues
Neurology, November 23, 2004; 63(10_suppl_4): S30 - S39.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
P. Camfield and C. Camfield
Childhood Epilepsy: What Is the Evidence for What We Think and What We Do?
J Child Neurol, April 1, 2003; 18(4): 272 - 287.
[Abstract] [PDF]


Home page
J Child NeurolHome page
L. J. Willmore and Y. Ueda
Genetics of Epilepsy
J Child Neurol, January 1, 2002; 17(1_suppl): S18 - S27.
[Abstract] [PDF]


Home page
NeurologyHome page
P. Pavone, R. Bianchini, R.R. Trifiletti, G. Incorpora, A. Pavone, and E. Parano
Neuropsychological assessment in children with absence epilepsy
Neurology, April 24, 2001; 56(8): 1047 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Sander, H. Schulz, K. Saar, E. Gennaro, M. C. Riggio, A. Bianchi, F. Zara, D. Luna, C. Bulteau, A. Kaminska, et al.
Genome search for susceptibility loci of common idiopathic generalised epilepsies
Hum. Mol. Genet., June 12, 2000; 9(10): 1465 - 1472.
[Abstract] [Full Text] [PDF]